Company Filing History:
Years Active: 2006-2015
Title: The Innovative Contributions of Sabine Gliesing to Pharmaceutical Development
Introduction
Sabine Gliesing, an accomplished inventor based in Jena, Germany, has made significant strides in the field of pharmaceutical development. With a total of six patents to her name, Gliesing’s innovative methods focus on the production of crystalline active ingredient particles, which are essential for the formulation of effective drugs.
Latest Patents
Her latest patents showcase groundbreaking techniques that have the potential to transform drug composition and delivery. One notable patent is titled "Method for producing crystalline active ingredient particles." This invention describes a method and device for generating crystalline active ingredient particles by crystallizing the active ingredient from a supersaturated solution on the surface of the particles. This process involves wet grinding in a supersaturated solution of the active ingredient and utilizing ultrasound in the subsequent cooling phase. The patent specifies that the resulting particles can have a mean size ranging from 10 to 500 micrometers, with a relative supersaturation of ≤90% in the liquid phase.
Another groundbreaking patent is focused on "Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs." This invention details a method for fabricating highly crystalline and stable microparticles that maintain a narrow size distribution. The newly formed microparticles are created from a suspension containing primary particles, a solution of the active substance, a non-solvent, and inert formed pieces. These microparticles demonstrate excellent stability, making them particularly suitable for fast-release pharmaceutical formulations.
Career Highlights
Throughout her career, Sabine Gliesing has contributed her expertise to prominent companies in the pharmaceutical sector, including Schering Aktiengesellschaft and Jesalis Pharma GmbH. Her innovative work has positioned her as a key figure in advancing methodologies for drug production.
Collaborations
Collaboration has been a crucial aspect of Gliesing’s career. She has worked alongside notable colleagues such as Detlef Grawe and Hagen Gerecke. Together, they have contributed to significant advancements in the field of pharmaceutical sciences, leveraging their combined expertise to innovate solutions that improve drug efficacy and safety.
Conclusion
Sabine Gliesing exemplifies the spirit of innovation in the pharmaceutical industry. Her commitment to the development of effective production methods for crystalline active ingredients has the potential to greatly enhance drug therapies. As she continues to build on her successes, Gliesing’s work promises to leave a lasting impact on pharmaceutical technology and patient care.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.